AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 33 filers reported holding AMBRX BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,122,424 | -27.9% | 9,923,689 | +3.2% | 6.66% | -24.9% |
| Q2 2023 | $158,281,911 | +208660.1% | 9,616,155 | +13.1% | 8.87% | +77.6% |
| Q1 2023 | $75,820 | +1329.5% | 8,500,000 | +263.8% | 4.99% | +1306.5% |
| Q4 2022 | $5,304 | -99.8% | 2,336,389 | 0.0% | 0.36% | +101.7% |
| Q3 2022 | $2,523,000 | -61.7% | 2,336,389 | -6.0% | 0.18% | -64.7% |
| Q2 2022 | $6,589,000 | -35.7% | 2,486,386 | 0.0% | 0.50% | -36.7% |
| Q1 2022 | $10,244,000 | -54.4% | 2,486,386 | 0.0% | 0.79% | -41.0% |
| Q4 2021 | $22,452,000 | -32.2% | 2,486,386 | 0.0% | 1.34% | -0.7% |
| Q3 2021 | $33,097,000 | -29.6% | 2,486,386 | 0.0% | 1.34% | -15.8% |
| Q2 2021 | $47,032,000 | – | 2,486,386 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $191,919,314 | 67.54% |
| Cormorant Asset Management, LP | 9,923,689 | $114,122,424 | 6.66% |
| COMMODORE CAPITAL LP | 3,518,556 | $40,463,394 | 4.73% |
| Ally Bridge Group (NY) LLC | 281,089 | $3,232,524 | 3.79% |
| Paradigm Biocapital Advisors LP | 3,488,596 | $40,118,854 | 2.72% |
| VR Adviser, LLC | 2,070,000 | $23,805,000 | 2.51% |
| Ghost Tree Capital, LLC | 525,000 | $6,037,500 | 1.99% |
| HighVista Strategies LLC | 193,701 | $2,227,562 | 1.03% |
| Ikarian Capital, LLC | 4,932 | $5,671,800 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 34,000 | $391,000 | 0.51% |